AS30255
New York Genome Center, Inc.
Reputation · trust score
A transparent 0–100 signal. Every entity starts at a neutral baseline of 65; threat-intel blocklists, exposure, reverse-DNS, routing and allocation each adjust it up or down. Higher is more trustworthy.
- Baseline (neutral) 65
- Trust score 65 / 100
Experimental · trust-vectors model v1.2.0 — a transparent heuristic, not a definitive verdict. How it works →
Top CIDR ranges
| CIDR | IPs | PTR Density | Organization | Country | State | City |
|---|---|---|---|---|---|---|
| 66.205.235.0/24 | 256 |
2.3%
|
New York Genome Center, Inc. | US | — | — |
| 69.80.224.0/24 | 256 |
0.0%
|
New York Genome Center, Inc. | US | — | — |
BGP Announced Prefixes
Live BGP anomalies →Prefixes AS30255 actually originates in BGP, observed across our RIPE RIS collectors. This live routing view can differ from the registry allocation above.
| Prefix | Announcement samples | Last seen |
|---|---|---|
| 69.80.224.0/24 | 10,696 | 2026-08-03 03:50:31 |
| 66.205.235.0/24 | 7,443 | 2026-08-03 04:16:19 |
Frequently Asked Questions
What is AS30255?
AS30255 is an Autonomous System Number assigned to New York Genome Center, Inc.. An ASN identifies a network that controls a specific set of IP addresses and determines how traffic is routed across the internet via BGP (Border Gateway Protocol).
How many IP addresses does AS30255 announce?
AS30255 announces 512 IPv4 addresses distributed across 2 routed CIDR prefixes. The network is registered in United States.
Who operates AS30255?
AS30255 is operated by New York Genome Center, Inc.. The organization is based in United States. You can view all IP ranges and related ASNs on the organization page.
What country is AS30255 registered in?
AS30255 is registered in United States. This indicates where the network operator is headquartered, though the IP addresses it announces may serve users globally.
